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Abstract: There are striking inequities in calcium intake between rich and poor populations.
Appropriate calcium intake has shown many health benefits, such as reduction of hypertensive
disorders of pregnancy, lower blood pressure particularly among young people, prevention of
osteoporosis and colorectal adenomas, lower cholesterol values, and lower blood pressure in the
progeny of mothers taking sufficient calcium during pregnancy. Studies have refuted some calcium
supplementation side effects like damage to the iron status, formation of renal stones and myocardial
infarction in older people. Attention should be given to bone resorption in post-partum women
after calcium supplementation withdrawal. Mechanisms linking low calcium intake and blood
pressure are mediated by parathyroid hormone raise that increases intracellular calcium in vascular
smooth muscle cells leading to vasoconstriction. At the population level, an increase of around
400–500 mg/day could reduce the differences in calcium intake between high- and middle-low-income
countries. The fortification of food and water seems a possible strategy to reach this goal.
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1. Introduction
Calcium is a mineral involved in a large number of vital functions [1,2]. Although research on
the role of calcium has been primarily focused on bone health, the effects of either dietary calcium or
calcium supplements have been oriented towards other health outcomes lately. An observation made
in the 1980s drew attention to the relationship between calcium intake and preeclampsia/eclampsia
during pregnancy [3]. This originated from the evaluation of the Mayan diet in Guatemala consisting
of soaking and cooking corn with limewater before grinding and the consequent high intake of calcium
found to be associated with a low frequency of preeclampsia/eclampsia [4]. The objective of this article
is to update the various effects of calcium on health supported by findings in randomised controlled
trials (RCTs) with considerations of its availability and intake and propose suggestions for strategies to
achieve adequate intake.
2. Sources of Calcium
Calcium intake is usually associated with the intake of dairy products such as milk, yogurt and
cheese, as they are rich sources of calcium. Calcium-rich foods are dairy products, especially hard
cheese that can provide 1 g of calcium per 100 g, whereas milk and yogurt can provide between
100 mg to 180 mg per 100 g. Cereals usually have around 30 mg per 100 g, however if they are
fortified, the amount can reach 180 mg per 100 g. Nuts and seeds are also rich in calcium, especially
almonds, sesame and chia that can provide between 250 to 600 mg per 100 g. Vegetables rich in calcium
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are kale, broccoli and watercress, which provide between 100 and 150 mg per 100 g [5]. However,
the impact that these foods have on total calcium intake depends on the population food consumption
patterns. Whereas dairy products represent around 14% of total dietary energy intake in developed
countries, they represent only around 4% of total energy intake in developing countries [6]. In this
way, some Asian countries have higher proportion of total calcium intake from non-animal foods such
as vegetables, legumes and grains than from dairy products, though they also have a much lower
calcium intake [6]. In the United states and in Holland, 72 and 58% of calcium supply come from dairy
products, respectively, whereas in China, only around 7% of total calcium intake comes from dairy
products, while most comes from vegetables (30.2%) and legumes (16.7%) [7–9] Fortified foods such as
cereals and juices can additionally become important sources of calcium.
Supplements are also a great dietary source of calcium for some populations. Some calcium
supplements, available with no prescription, have up to 1000 mg of calcium per tablet, which represents
the nutritional requirements for most adults. However, the use of supplements also varies between
countries. In the United States and Canada, around 40% of the adult population was reported to have
taken calcium supplements in the month before the interview, and this figure increased to 70% in
the older women group [3,6,10]. On the other hand, in Argentina and in Holland, very few women
reported taking calcium supplements, even during pregnancy [5,11,12].
3. Calcium Recommendations
Calcium requirements are high during all stages of life [13]. Dietary reference values for individuals
over 19 years of age vary from 1000 mg to 1300 mg, depending on the reference guidelines [1,2,14–16]
(Table 1).
Table 1. Dietary reference values for Calcium from different sources.






























0–6 month 400 525 200 (AI) 240–300 300–400
6–12 month 400 525 260 (AI) 240–300 300–400 280 (AI)
1–3 year 275 350 500 700 500 390 450
4–6 year 350 450 800 1000 440 600 680 800
7–10 year 425 550 800 1000 1300 680 800
Males
11–14 year 750 1000 1100 1300 1040 1300 960 1150
15–18 year 750 1000 1100 1300 1040 1300 960 1150
19–24 year 525 700 800 1000 840 1000 860 1000
25–50 year 525 700 800 1000 840 1000 750 950
50 year 525 700 800 1000 840 1000/1300 750 950
Females
11–14 year 625 800 1100 1300 1040 1300 960 1150
15–18 year 625 800 1100 1300 1040 1300 960 1150
19–24 year 525 700 800 1000 840 1000 860 1000
25–50 year 525 700 800 1000 840 1000 750 950
50 year 525 700 1000 1200 840 1000 750 950
Pregnancy
14 to 18 year Same asnon-pregnant
Same as





19 and older Same asnon-pregnant
Same as





Lactation plus 550 plus 550 1100/800 1300/1000 1040 1000 Same asnon-lactating
Same as
non-lactating
SACN: UK Scientific Advisory Committee on Nutrition. IOM: USA Institute of Medicine. EFSA: European Food
Safety Authority; AI: Average Intake. * No data available.
The dietary reference values are established to account for the needs of growth, development,
functioning and health maintenance [15]. The requirements are calculated on the basis of a selected
health outcome. The USA Institute of Medicine (IOM) conducted a review to assess the effect of calcium
on health so as to update the dietary reference intakes for calcium in 2010 [2]. The review finally
recommended to base the requirements for calcium on its effects on bone health and concluded that the
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evidence of the effect of calcium on cancer, cardiovascular disease, diabetes and autoimmune disorders
was inconsistent, inconclusive as to causality and insufficient to inform nutritional requirements [7].
Besides, in order to establish calcium intake upper limits, the review evaluated the following clinical
outcomes: all-cause mortality, cancer (incidence and mortality), soft tissue calcification, renal outcomes
and adverse events reported in RCTs. No evidence of association was found in this report for mortality,
soft tissue or cancer. An increased risk of renal stone [Hazard Ratio 1.17 (95% CI 1.02–1.34)] was
reported in only one trial in women aged 50 to 79 years who received vitamin D3 400 IU supplements
in combination with 1000 mg of calcium supplements [17]. Of the 63 included RCTs, 10 reported
adverse events, mainly related to higher gastrointestinal discomfort in the groups receiving calcium
and or Vitamin D supplements. The upper limit was set to 2500 mg/day for people aged 19 to 50 years
and to 2000 mg/day for older people.
During pregnancy, most guidelines acknowledge the increased demand of calcium; however,
while some guidelines increase recommendations up to 1300 mg/day to achieve a positive balance,
other guidelines state that metabolic adaptations during pregnancy compensate the required calcium
demand [2,16,18–20]. The IOM set in 2010 the dietary intake upper limit for pregnant women to
3000 mg/day for those aged 14 to 18 years and to 2500 for older ones [7], whereas the FAO/WHO
recommendation of 2001 acknowledged that the risk of kidney stones from dietary hypercalciuria
might be negligible and set the upper limit to 3000 mg/day independent of age. Since 2013, WHO
recommends that all pregnant women from areas of low dietary calcium intake receive calcium
supplementation from 1500 to 2000 mg/day from 20 weeks´ gestation, as evidence from randomized
control trials shows a reduction of the risk of preeclampsia [21,22].
4. Global Calcium Intake. Inequities
In most low- and middle-income countries, the daily calcium intake is well below recommendations;
however, low intakes are also observed in special age groups such as adolescents of high-income
countries [23–26].
A review reporting the global mean dietary calcium supplies from FAO balance sheets of different
countries shows that in 2011, the global calcium supply at population level was 684 SD± 211 mg per
person per day [27]. Using these data, the review also calculated that between 1992 and 2011, the global
calcium risk of deficiency decreased from 76% to 51% and that most of those countries at risk (90%) in
2011 were located in Africa and Asia.
A review including studies reporting calcium dietary intake found that the average national
dietary calcium intake ranges from 175 to 1233 mg/day (78 studies from 74 countries). Many countries
in Asia have an average dietary calcium intake of less than 500 mg/day. Countries in Africa and South
America mostly have low calcium intake, between about 400 and 700 mg/day, although there was no
information for many countries [28].
Similarly, a recent systematic review of diets in 195 countries based on nationally or subnationally
representative nutrition surveys jointly with many dietary data sources of the Global Health Data
Exchange for nationally or subnationally representative nutrition surveys provides information about
age-standardised intake of dietary factors among adults aged 25 years or older at the global and
regional level in 2017. These data show an average global calcium daily intake around 400 mg/day.
Lower values were seen in Sub-Sharan African countries and in Southeast Asia, with figures around
200 mg/day. In high-income-countries (HICs), calcium daily intake was around 600–800 mg/day [29].
A review reporting dietary intakes of pregnant women shows consistently low calcium intakes
across Asian, African and Latin American countries (105 studies, 73,958 pregnant women from
37 countries) [24,26]. The mean calcium intake in pregnant women of low- and middle-income
countries was 648 mg/day (95% confidence interval (CI) 569–727) whereas that from high-income
countries was 948 mg/day (95% CI 872–1024) [30,31].
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5. Calcium and Blood Pressure
Epidemiological studies associated dietary calcium with blood pressure in deprived communities
of Guatemala [3]. This population, with poor food intake and limited access to prenatal care, had an
incidence of preeclampsia and eclampsia comparable to that of populations with higher resources [32].
Despite having a diet short on nutrients, they had a relatively high intake of calcium. Their diet is
based on corn tortillas prepared according to the Mayan tradition that consists of cooking corn with
limestone and leave it to soak overnight in hot water [3]. In this way, the grains of corn increase their
calcium content, improving their nutritional value. After milling, the flour obtained from grains that
underwent this process had an average of 196 mg of calcium per 100 g, while corn flour commonly
contains between 10 and 15 mg of calcium per 100 g.
Observational studies also reported an inverse association between water hardness and
cardiovascular diseases [33–35]. Water hardness is determined by minerals in water, firstly calcium
and secondly magnesium [36]. In 1972, the WHO published a general review of these findings [37].
However, later studies showed a weak or inconsistent relationship, possibly because the contribution
of calcium from hard water to the total calcium intake was considerably smaller in the populations
examined or because more significant risk factors of cardiovascular disease than that of a low dietary
calcium intake existed [33].
Studies in animals and humans have shown an inverse relationship between calcium intake
and blood pressure [38,39]. Normotensive rats fed a free-calcium diet significantly increased their
systolic blood pressure (SBP) between 15 to 35 mmHg in comparison with rats fed a normal calcium
diet [38,40,41]. On the other hand, normotensive and hypertensive rats supplemented with calcium had
significantly lower values of SBP [42–45]. A systematic review has shown that calcium supplementation
reduces SBP in normotensive adults by 1.14 mmHg (95% CI: −2.01 to −0.27) with doses of calcium of
1000 to 1500 mg/day and by 2.79 mmHg (95% CI: −4.71 to −0.86) with doses of calcium equal to or
over 1500 mg/day [46]. In this review, it was found that calcium supplementation had the greatest
effect in young adults of less than 35 years, as their systolic blood pressure was reduced by 2.11 mmHg
(95% CI: −3.58 to −0.64). A similar systematic review in hypertensive adults found that calcium
supplementation reduced SBP by −1.86 mm Hg (95% CI: −2.91 to −0.81) and diastolic BP (DBP) by
−0.99 mm Hg (−1.61 to −0.37). However, higher reductions were found in people with a relatively
low calcium intake (less or equal to 800 mg/day), in which calcium supplementation reduced SBP
by −2.63 (−4.03 to −1.24) and DBP by −1.30 (−2.13 to −0.47) [47]. Another similar systematic review
also showed that calcium supplementation as compared to control induced a statistically significant
reduction of SBP (mean difference: −2.5 mmHg, 95% CI: −4.5 to −0.6, I2 = 42%) but not of DBP (mean
difference: −0.8 mmHg, 95% CI: −2.1 to 0.4, I2 = 48%) [48].
A systematic review that included 13 RCTs and 15730 pregnant women estimated that calcium
supplementation compared to placebo reduced the high blood pressure relative risk (RR) to 0.65,
(95% CI: 0.53 to 0.81) and, although with low quality of evidence, also the risk of preeclampsia by 55%,
with RR 0.45, (95% CI: 0.31 to 0.65) [49]. In populations with low calcium intake below 800 mg/day,
the effect was even higher (RR 0.36, 95% CI: 0.20 to 0.65). A recent RCT has shown a reduction in
the incidence of preeclampsia of 34% (RR 0.66, 95% CI: 0.44–0.98) in women supplemented with
500 mg/day of calcium before and in early pregnancy, comparing groups of women with good adherence
to supplement intake, either calcium or placebo [50]. Both groups received calcium supplementation
corresponding to 1.5 g/day after 20 weeks´ gestation.
6. Calcium Intake and Effect on Blood Pressure
Blood pressure is regulated by intracellular calcium in vascular smooth muscle cells, through
vasoconstriction and variations of the vascular volume [51,52]. Low calcium intake seems to trigger
both mechanisms, raising plasma parathyroid hormone (PTH) levels, that increase intracellular calcium
directly or through calcitriol activation, and stimulating the renin–angiotensin–aldosterone signalling
pathway that produces sodium and water reabsorption, thus increasing the vascular volume [42,52–55].
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Parathyroidectomized rats in comparison with sham-operated rats did not show an increase in blood
pressure after 10 weeks of a calcium-free diet [54].
There is no established threshold for the benefits of calcium intake on blood pressure; in humans
and animals with low calcium intake, blood pressure is improved when calcium intake is increased to
reach the recommended levels. No benefits for blood pressure by increased calcium intake have been
observed in humans and animals with adequate calcium intake [46,49,56,57]
7. Calcium Intake during Pregnancy and the Effects on the Offspring
The effect of calcium supplementation during pregnancy has also been explored. The follow-up
of children whose mothers were involved in a RCT of calcium supplementation showed that children
whose mothers were in the calcium group had a reduction in the risk of high blood pressure (above the
90th percentile) at seven years of age in comparison with children whose mothers were in the placebo
group (RR 0.59; 95% CI: 0.39 to 0.90) [56]. A systematic review shows that children whose mothers
received calcium supplementation had a reduction of −1.92 mm Hg (95% CI −3.14 to −0.71) in SBP at
age 1 to 9 years [58].
A follow-up until 52 weeks of age of offspring of rats whose mothers had a low calcium intake
during pregnancy showed values of SBP of 12.1 mmHg (95% CI: 8.8 to 15.4, p < 0.0001) higher than the
offspring of rats whose mothers had a normal calcium diet during pregnancy [59].
In the RCT mentioned above, children whose mothers were in the calcium group showed a 27%
reduction in the risk of developing dental caries at 12 years of age in comparison with children whose
mothers were in the placebo group (RR: 0.73, CI 95%: 0.62; 0.87) [60].
8. Other Effects of Calcium Intake on Health
An adequate dietary calcium intake has been associated not only with the prevention of
hypertensive disorders of pregnancy and blood pressure reduction but also with low-density lipoprotein
(LDL) cholesterol levels and prevention of osteoporosis and colorectal adenomas [13,61,62].
8.1. Cholesterol
A systematic review of calcium supplementation and lipid metabolism reported that calcium
supplementation reduced LDL cholesterol [−0.12 mmol/L (95% CI: −0.22 to −0.02)] and increased
high-density lipoproteins (HDL) cholesterol [0.05 mmol/L (95% CI: 0.00 to 0.10) [63]. The authors
explained that possible mechanisms of these effects by the increase in dietary calcium include the
suppression of calcitrophic hormones that reduce intracellular calcium in adipocytes, thus stimulating
lipogenesis and lipid storage [63]. Besides, dietary calcium may decrease serum cholesterol by
inhibiting cholesterol and saturated fatty acid absorption [64].
8.2. Bone Health
A systematic review from 2006 that included 19 studies involving 2859 children found that calcium
supplementation had a small effect on total body bone mineral content (standardised mean difference
0.14, 95% CI: 0.01 to 0.27) and upper limb bone mineral density (0.14, 0.04 to 0.24), and this effect
persisted after the end of supplementation only for the upper limb bone mineral density (0.14, 0.01 to
0.28) [65]. The benefits of calcium supplementation seem to be greater in children and adolescents with
low calcium intake [66]. Calcium effects in other age groups were usually evaluated in combination
with vitamin D, so data for calcium alone are limited [17].
The US preventive Task Force in 2013 did not recommend supplementation with vitamin D
or calcium for the prevention of fractures in community-dwelling adults; however, the evidence
was updated in 2016, and with newer data from the Women´s Health Initiative study, the new
meta-analysis showed a 15% reduction on the incidence of fractures and a 30% reduction in hip
fractures in middle-aged to older adults [67,68].
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8.3. Recurrent Colorectal Adenomas
A systematic review of randomised controlled trials found that calcium supplementation with
doses from 1200 to 2000 mg/day and treatment duration from 36 to 60 months reduced the risk of
recurrent colorectal adenomas (RR = 0.89, 95% CI: 0.82–0.96, 5 studies, 2984 participants) [69].
It was proposed that calcium binds bile acids in the bowel lumen, inhibiting their proliferative
and carcinogenic effects [70]. In support of this hypothesis, studies in animals have indicated
a protective effect of dietary calcium on bile-induced mucosal damage and experimental bowel
carcinogenesis [71,72].
9. Calcium Supplementation Concerns
9.1. Supplements and Renal Stones
There is some controversy as to whether increasing calcium intake increases the risk of kidney
stone formation, as one RCT that evaluated the effect of 500 mg of calcium plus 200 units of Vitamin
D3 on the risk of fracture in postmenopausal women showed an increased risk of renal stones (hazard
ratio, 1.17; 95% CI: 1.02 to 1.34) [73]. We selected studies included in a systematic review of calcium
supplementation and incidence of kidney stones that evaluated an intervention consisting of calcium
supplementation alone in non-pregnant subjects [74]. We found five studies in postmenopausal or
elderly women with a total of 2038 subjects, randomised to calcium or placebo. We meta-analysed
the results and found a null effect of calcium supplementation compared to placebo (RR 0.66, 95% CI:
0.19, 2.34).
A systematic review showed that calcium supplementation during pregnancy did not increase
the risk of urolithiasis (RR 1.52, 95% CI: 0.06, 40.67) or renal colic (RR 1.75, 95% CI: 0.51, 5.99) as shown
in two studies with 12901 women [75].
Moreover, a secondary analysis of 7982 women with a history of nephrolithiasis participating in a
prospective study found that the proportion of calcium absorption decreased with the increase of both
dietary and supplement calcium intake and that increased calcium intake reduced the likelihood of
nephrolithiasis by 45–54% (p = 0.03) [76].
Nowadays, dietary calcium restriction is not recommended for stone formers with nephrolithiasis;
on the contrary, diets with more than 1 gram of calcium per day could be protective against stone
formation [77]. Kidney stones are mainly composed of calcium combined with oxalate or phosphate [78].
The calcium remaining in the intestine would impede the absorption of products associated with the
risk of renal stones, such as oxalates, and the intake of calcium supplements during meals would
decrease the absorption of oxalates and thus the formation of stones [74].
9.2. Calcium Supplements and Myocardial Infarction
Calcium supplements are commonly used to prevent fracture in postmenopausal women [1,7].
However, the use of calcium supplements in postmenopausal women was discouraged after a narrative
review showing a potential increase of adverse events such as atherosclerotic vascular disease in
women from New Zealand receiving calcium supplements [79].
However, a newer systematic review and meta-analysis including 18 RCTs involving 63,564 elderly
women participants concluded that calcium supplementation with or without vitamin D had no effect
on coronary heart disease or all-cause mortality risk [80–82]. This review reported cardiovascular
events clinically verified by hospital records or death certificates and found that the RR for all-cause
mortality was 0.96 (95% CI: 0.91–1.02; p = 0.180), that for CHD events was 1.02 (95% CI: 0.96–1.09;
p = 0.510) and that for myocardial infarction was 1.08 (95% CI: 0.92–1.26; p = 0.320).
9.3. Calcium Supplements and Iron Absorption
There have been concerns related to the effects of calcium supplements on iron absorption based on
short-term studies reporting that calcium supplements inhibit iron absorption by 28 to 55% depending
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on the dose, type of salt used, time of supplementation and the presence in the food of hem or non-hem
iron [83]. However, evidence shows no effect on iron status of prolonged calcium supplementation
taken at the same time or separate of meals [84–89]. A study of infants supplemented with calcium
glycerophosphate or placebo found no difference in iron status at four and nine months, with mean
changes in serum ferritin of −24.5 and −46.6 µg/L in intervention and placebo groups, respectively [90].
Another study in which adolescent girls received 1 g of calcium citrate malate/day for 4 years did not
find differences in the iron status; serum ferritin average concentrations in the supplemented group at
baseline and years 1, 2, 3 and 4 were 29.1 ± 1.3, 31.1 ± 1.5, 31.1 ± 1.6, 30.6 ± 2.0 and 29.6 ± 1.9 µg/L,
respectively, whereas in the placebo group, the concentrations were 29.3 ± 1.4, 33.8 ± 1.7, 32.3 ± 1.4,
30.9 ± 1.5 and 29.5 ± 1.6 µg/L, respectively (p = 0.88, 0.23, 0.56, 0.88 and 0.96 for baseline and years
1, 2, 3 and 4, respectively) [91]. Similarly, another study of 113 adolescent girls supplemented with
500 mg of calcium/day as calcium carbonate found no differences in iron status markers. At one year,
hemoglobin was 136 g/L in the supplemented group and 134 g/L in the placebo group (p = 0.31); ferritin
was 25.4 µg/L in the supplemented group and 26.1 µg/L in the placebo group (p = 0.73) [88].
A study that supplemented post-partum women with 500 mg of calcium/day as calcium carbonate
found that mean serum ferritin was 28.4 mg/L in the supplemented participants and 27.5 mg/L in
women in the placebo group (p > 0.5) [87]. A study in 24 healthy individuals also showed that
supplementation with 1200 mg of calcium/day as calcium carbonate had no significant effect on
hemoglobin or hematocrit at 6 months. Mean hemoglobin at 6 months was 136 g/L in the calcium
group compared to 139 ± 4 in the control group and hematocrit was 0.416 ± 0.013 in the calcium group
compared to 0.424 ± 0.009 in the control group [92].
With this evidence, it has also been recommended that pregnant women take calcium
supplementation together with iron and folic acid to improve adherence [93].
9.4. Calcium Intake and Maternal Bone Post-Partum Resorption
Of concern are the findings in a RCT in rural Gambian women with very low calcium intake
showing that supplementation during pregnancy with 1.5 g calcium/day resulted in significantly lower
maternal bone mineral content, bone area, and bone mineral density at the hip throughout 12 months
of lactation compared to women in the placebo group [94]. These women also experienced greater
decreases in bone minerals during lactation at the lumbar spine and distal radius and had biochemical
changes consistent with greater bone mineral mobilization that could last for a long time [94,95].
The authors postulated that, possibly, calcium supplementation disrupted the processes of calcium
conservation previously seen in these women with a very low calcium diet and that the withdrawal of a
calcium supplement produced a rise in parathyroid hormone (PTH) secretion, promoting renal calcium
reabsorption, intestinal calcium absorption and bone resorption [94]. However, RCTs of calcium
supplementation during pregnancy performed in other populations with low and normal calcium
intake in the USA, Mexico and Brazil showed contradictory results, since women in the calcium group
showed reduced postpartum bone resorption and improved bone recovery [96–99].
10. Calcium Intake and Drug Interactions
There are some reports showing interactions of calcium supplements with drugs, with the majority
of them having a moderate or minor Interaction Rating. Major interactions have been reported with
antiretroviral drugs like Dolutegravir and Elvitegravir, and the recommendation is to take these drugs
separately from calcium supplements. Calcium can decrease the absorption of some antibiotics, and the
recommendation is to take calcium supplements apart from these antibiotics. Besides, supplements
with high amounts of calcium are not advised when taking some calcium channel blockers drugs [100].
As we will further develop in this manuscript, our recommendation is to increase calcium intake
through diet by eating calcium-rich foods or calcium-fortified foods, as calcium supplementation does
not look like a feasible strategy to increase calcium intake in all populations.
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11. Discussion
From the above information, it can be concluded that adequate calcium intake has many health
benefits besides its favourable effects on bone health, and action should be taken to ensure an adequate
calcium intake (Table 2). The effect of calcium supplementation on pregnancy outcomes is the one with
more evidence as it received more research attention. However, the effect of calcium supplementation
on lowering blood pressure, particularly at an early age, is also very important for its impact on
the prevention of cardiovascular complications later in life. Further studies are required to better
understand the modeling effect of calcium intake during pregnancy on progeny blood pressure.
Table 2. Effect of calcium intake on health outcomes. Evidence from randomised controlled trials (RCT)
and systematic reviews of randomised controlled trials.









Meta-Analysis Calcium supplementation compared to placebo reduced therisk of preeclampsia, RR 0.36, (95% CI: 0.20 to 0.65) [48].
High blood
pressure Pregnant women Meta-Analysis
Calcium supplementation compared to placebo reduced the
high blood pressure relative risk (RR) to 0.65, (95% CI: 0.53 to
0.81) [48].
Blood pressure
Blood pressure Normotensive adults Meta-Analysis
Calcium supplementation reduced systolic blood pressure
(SBP) in adults by 1.14 mmHg (95% CI: −2.01 to −0.27) with
doses of calcium 1000 to 1500 mg/day and by 2.79 mmHg (95%
CI: −4.71 to −0.86) with doses of calcium equal to or over
1500 mg/day. Calcium supplementation had the greatest effect
in young adults of less than 35 years as their SBP was reduced
by 2.11 mmHg (95%CI: −3.58 to −0.64) [45].
Blood pressure Hypertensive adults
Calcium supplementation reduced SBP by −1.86 mm Hg
(95% CI: −2.91 to −0.81) and diastolic BP (DBP) by −0.99 mm





In people with relatively low calcium intake (≤ 800 mg per
day) calcium supplementation reduced SBP by −2.63 (95% CI:
−4.03 to −1.24) and DBP by −1.30 (95% CI: −2.13 to −0.47) [46].
Blood pressure Hypertensive adults
Calcium supplementation as compared to control induced a
statistically significant reduction in SBP (mean difference:
−2.5 mmHg, 95% CI: −4.5 to −0.6, I(2)= 42%) but not DBP
(mean difference: −0.8 mmHg, 95% CI: −2.1 to 0.4,







Calcium supplementation showed that children whose
mothers received calcium supplementation had, at seven
years of age, a reduction in the risk of high blood pressure
(above the 90th percentile) in comparison with children whose
mothers were in the placebo group (RR 0.59; 95% CI: 0.39 to
0.90) [55].
Cholesterol LDL and HDLCholesterol Adults Meta-Analysis
Calcium supplementation reduced low-density lipoprotein
(LDL) cholesterol [−0.12 mmol/L (95% CI: −0.22 to −0.02)] and
increased high-density lipoprotein (HDL) cholesterol







Calcium supplementation with doses from 1200 to
2000 mg/day and treatment duration from 36 to 60 months
reduced the risk of recurrent colorectal adenomas, RR = 0.89,
(95%CI: 0.82–0.96) [65].
Bone health Bone mineraldensity Children Meta-Analysis
Calcium supplementation had a small effect on total body
bone mineral content (standardised mean difference 0.14, 95%
CI: 0.01 to 0.27) and upper limb bone mineral density (0.14,
95% CI: 0.04 to 0.24), and this effect persisted after the end of
supplementation only in the upper limb (0.14, 95% CI: 0.01 to
0.28) [61].
Renal stones Urolithiasis Individuals withosteoporosis Meta-Analysis
Calcium supplementation compared to placebo, RR 0.66
[95% CI 0.19, 2.34]; 5 studies in postmenopausal or elderly
women including 2038 subjects [70].
Urolithiasis Pregnant women Meta-Analysis
Calcium supplementation during pregnancy did not increase
the risk of urolithiasis, RR 1.52 [95% CI: 0.06, 40.67] or renal
colic, RR 1.75 [95% CI; 0.51, 5.99] in 2 studies with
12901 women [71].
Other benefits of adequate calcium intake have been reported, such as higher bone mineral
accretion at early ages and prevention of osteoporosis and colorectal cancer.
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Many of the reported deleterious effects of calcium supplementation were recently reviewed,
and previous results were questioned. A recent meta-analysis showed no effect on coronary heart
disease or all-cause mortality risk in postmenopausal women supplemented with calcium. Long-term
calcium supplementation did not show a detriment to iron status. The effect of calcium intake on renal
stones formation was shown to be contradictory, and new evidence shows that a diet with an adequate
calcium intake actually prevents the formation of calcium stones.
Of concern are the calcium resorption outcomes reported in the follow-up of Gambian women that
had received calcium supplementation during pregnancy. Whereas other trials have shown opposite
results to those of the Gambian study, more research on the effects of calcium supplementation on
bone health after lactation is required to better understand these particular findings.
All this evidence suggests that every subject should attain an adequate calcium intake. Inequities
in calcium intake are striking. Strategies to improve calcium intakes should be evaluated according to
the target population.
Individuals with low calcium intake should be counselled on the importance of calcium intake and
guided on achieving an adequate intake, especially if belonging to high-risk groups such as children,
adolescents and women (with emphasis on the reproductive period). Populations at risk of low calcium
intake should be identified, and strategies should be designed according to each particular situation.
Efforts should be made to achieve calcium recommendations both at individual and global levels,
and strategies will depend on the intake level of each population. Calcium intakes in low- and
middle-income countries (LMICs) are extremely inadequate, and strategies should include the whole
population; however, even in high income countries, certain population groups such as pregnant
women often do not meet the recommendations, and strategies should probably be targeted specifically
to those groups.
Supplementing with calcium individuals that already reach the requirements has been shown to be
of no benefit. Even in the NICHD/NIH study that showed no overall effect of calcium supplementation
in women with high basal intake (mean 1114 mg/day), there was a tendency towards a lower incidence
of preeclampsia according to the quintiles of basal calcium intake [101]. A decrease in preeclampsia
incidence, although not statistically significant, was observed in women in the quintiles of calcium
intake below the requirements [101].
Another point to discuss regards the amount of calcium these strategies should provide to achieve
an adequate intake. Theoretically, this amount should be determined after assessment of each specific
population. A review of calcium intake during pregnancy showed an average difference in calcium
intake of around 400–500 mg/day between LMICs and HICs. WHO guidelines recommend calcium
supplementation of 1.5 to 2 g/day to pregnant women from populations with low basal intake; however,
a newer review showed that supplementation with 500 mg/day of calcium during pregnancy had
effects similar to those of supplementation with higher doses [102].
There are three broad approaches to improve dietary calcium intake: one is a behavioural
intervention that, although ideal, relies on personal habits and abilities, the second one is
supplementation that targets individuals, and the third one is food fortification that aims at improving
the dietary intake of a whole population. Recommendations to improve dietary calcium intake by
increasing the consumption of calcium-rich foods and/or taking calcium supplements have been
around for many years; however, these recommendations have shown little impact in LMICs.
Supplementation strategies, though well-evaluated in research studies, have many limitations
for implementation in LMICs, such as end user costs, poor access to the health system and low
long-term compliance. In addition, some deleterious effects discussed above, such as post-partum
bone resorption, gastrointestinal discomfort and cardiovascular effects on adult women, as well as
some drug interactions have been reported in subjects taking calcium supplements.
Food fortification looks like as a promising approach, since it can reach different age groups for a
long period of time and, if properly designed, does not require changing the dietary habits or taking
pills, which allows to reach populations outside the healthcare system.
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The calcium dietary intake gap between LMICs and HICs is around 400–500 mg/day, a feasible
amount to achieve with food fortification. Taking into account the benefits shown during pregnancy
on mother and foetus and the benefits on bone mineral accretion and prevention of bone loss, it can
be assumed that achieving an adequate calcium intake at population level would imply long-lasting
benefits and will reduce the differences in many health outcomes between LMICs and HICs.
Food fortification has been used for more than 80 years [103]. Mandatory food fortification has
contributed to health improvement, lowering the incidence of goitre, beriberi and pellagra. Currently,
more than 130 countries have mandatory micronutrient fortification of salt, and around 85 have
mandatory micronutrient fortification of wheat flour. WHO evaluation of food fortification nutrition
interventions recommends the fortification of maize flour with iron and folic acid and the fortification
of salt with iodine and iron powders [104]. Improved zinc, vitamin A, folic acid, vitamin D and
calcium deficiencies at population level were also achieved by fortifying different staple foods. Besides
fortification, the restoration of micronutrients naturally present in foods that are removed during
industrialization processes, such as vitamin B complex in maize flour, is used. The restoration of
calcium to wheat flour has been used in the UK since 1943. However, despite this vast experience,
food fortification products are not always accessible to the low socioeconomic groups, and strategies
should be developed to reach them [103].
Most experiences include staple food fortification, as they are generally consumed in good
amounts, and research is required to determine the best staple food to be fortified for each specific
population. On the other hand, water fortification looks promising, since water is universally consumed
and taking into account the global obesity figures water does not imply any change in energy intake.
Ecological studies have found an inverse relationship between water hardness and cardiovascular
mortality [33,105]. Calcium bioavailability from calcium-rich waters is similar to that of milk [13,106,107].
Water fortification with calcium would in some way mimic the situation of populations drinking
hard water. Although there are some studies on this topic, more research is required. Studies on
water fortification include examples of fortification of public water supplies with fluoride to prevent
dental cavities that have been implemented for more than 50 years in more than 25 countries; however,
most evidence of its effects comes from observational studies [108–111]. There are some studies in
Asia regarding iodized water; however, as iodine has limited stability, this strategy is not always
cost-effective [103]. Iron and ascorbic acid water fortification to prevent iron deficiency anaemia has
been explored and, although successful, is still being researched [112,113].
It has been estimated that in LMICs, improved drinking water can reach the majority of urban
areas (92%), and 70% of the urban population has access to piped water within their household.
In contrast, in rural areas, only 25% of the population has access to this type of service [114]. Research
into the feasibility of calcium-fortified water deserves to be considered, taking into account different
water supplies.
12. Conclusions
Achieving calcium intake recommendations could involve major health benefits to individuals and
populations and that it is fully justified to make efforts to attain such achievement. As in the majority
of health situations, inequities in calcium intake are clearly shown at the global level. Regarding the
achievement of calcium recommendations at the population level, long-term beneficial effects can be
expected, including the improvement of health in future generations.
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